Using Circulating Soluble Serum Mediator Profiles to Understand the Mechanisms Driving Disease Flare and Drug-free Remission in Rheumatoid Arthritis

被引：0
|
作者：
Anderson, Amy [1 ,2 ]
Rayner, Fiona [1 ,2 ]
Degnan, Abbie [1 ,2 ]
Wilson, Imogen [1 ,2 ]
Diboll, Julie [1 ,2 ]
Sim, Jasmine [1 ,2 ]
Melville, Andrew [3 ]
Siebert, Stefan [3 ]
McInnes, Iain [4 ]
Goodyear, Carl [3 ]
Hilkens, Catharien [1 ,2 ]
Filer, Andrew [5 ,6 ]
Raza, Karim [5 ,6 ]
Buckley, Christopher [7 ]
Baker, Kenneth [1 ,2 ]
Pratt, Arthur [1 ,2 ]
Isaacs, John [1 ,2 ]
机构：
[1] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[3] Univ Glasgow, Sch Infect & Immun, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland
[4] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland
[5] Univ Birmingham, Rheumatol Res Grp, Inst Inflammat & Ageing, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England
[6] Univ Birmingham, Clin Res Facil, Birmingham, W Midlands, England
[7] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1662
引用
收藏
页码：3387 / 3389
页数：3
相关论文
共 50 条
  • [21] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Bykerk, Vivian P.
    Burmester, Gerd R.
    Combe, Bernard G.
    Furst, Daniel E.
    Huizinga, Tom W. J.
    Ahmad, Harris A.
    Emery, Paul
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) : 2225 - 2231
  • [22] PREDICTORS OF DRUG-FREE REMISSION FOLLOWING TREATMENT WITH ABATACEPT (IN COMBINATION WITH METHOTREXATE OR AS MONOTHERAPY) IN EARLY RHEUMATOID ARTHRITIS
    Emery, Paul
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Combe, Bernard G.
    Furst, Daniel E.
    Karyekar, Chetan S.
    Wong, Dennis A.
    Huizinga, Tom W. J.
    RHEUMATOLOGY, 2015, 54 : 28 - 29
  • [23] Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study
    Motomu Hashimoto
    Moritoshi Furu
    Wararu Yamamoto
    Takanori Fujimura
    Ryota Hara
    Masaki Katayama
    Akira Ohnishi
    Kengo Akashi
    Shuzo Yoshida
    Koji Nagai
    Yonsu Son
    Hideki Amuro
    Toru Hirano
    Kosuke Ebina
    Ryuji Uozumi
    Hiromu Ito
    Masao Tanaka
    Koichiro Ohmura
    Takao Fujii
    Tsuneyo Mimori
    Arthritis Research & Therapy, 20
  • [24] Predictors of Drug-Free Remission Following Treatment with Abatacept (in Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis
    Emery, P.
    Burmester, Gerd
    Bykerk, Vivian P.
    Combe, B.
    Furst, D. E.
    Barre, E.
    Karyekar, C. S.
    Wong, D.
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1084 - S1084
  • [25] Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study
    Hashimoto, Motomu
    Furu, Moritoshi
    Yamamoto, Wararu
    Fujimura, Takanori
    Hara, Ryota
    Katayama, Masaki
    Ohnishi, Akira
    Akashi, Kengo
    Yoshida, Shuzo
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Hirano, Toru
    Ebina, Kosuke
    Uozumi, Ryuji
    Ito, Hiromu
    Tanaka, Masao
    Ohmura, Koichiro
    Fujii, Takao
    Mimori, Tsuneyo
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [26] PHENOTYPES OF DRUG-FREE RHEUMATOID ARTHRITIS FLARE AND IMPACT OF RESIDUAL SUBCLINICAL ECOGRAPHIC JOINT INJURY IN ACPA POSITIVE AND ACPA NEGATIVE DISEASE
    Cassione, E. Bozzalla
    Grignaschi, S.
    Xoxi, B.
    Greco, M. I.
    Luvaro, T.
    Mazzucchelli, I.
    Bugatti, S.
    Montecucco, C.
    Manzo, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1222 - 1222
  • [27] Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Vivian P. Bykerk
    Gerd R. Burmester
    Bernard G. Combe
    Daniel E. Furst
    Tom W. J. Huizinga
    Harris A. Ahmad
    Paul Emery
    Rheumatology International, 2019, 39 : 945 - 945
  • [28] Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?
    Liu, Di
    Yuan, Na
    Yu, Guimei
    Song, Ge
    Chen, Yan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (08): : 3758 - 3775
  • [29] Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study (vol 105, 102298, 2019)
    Baker, Kenneth F.
    Skelton, Andrew J.
    Lendrem, Dennis W.
    Scadeng, Adam
    Thompson, Ben
    Pratt, Arthur G.
    Isaacs, John D.
    JOURNAL OF AUTOIMMUNITY, 2022, 132
  • [30] Improved outcomes of drug-free remission with DAS-steered therapy compared to conventional therapy for rheumatoid arthritis
    van der Woude, D.
    Visser, K.
    Brand, R.
    Klarenbeek, N. B.
    van der Linden, M. P. M.
    Mailee, C.
    de Beus, W. M.
    Kerstens, P. J. S. M.
    Dijkmans, B. A. C.
    Huizinga, T. W. J.
    Mil, A. H. M. van der Helm-van
    Allaart, C. F.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S919 - S920
12345